How much time does it take to prescribe a new medication?

Derjung M. Tarn, Debora A Paterniti, Richard L Kravitz, John Heritage, Honghu Liu, Sue Kim, Neil S. Wenger

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Objective: To measure the length of time spent discussing all aspects of new prescriptions and guideline-recommended aspects of counseling, and to evaluate factors associated with duration of discussion. Methods: We analyzed tape recordings in which 181 patients received 234 new medication prescriptions from 16 family physicians, 18 internists, and 11 cardiologists in 2 healthcare systems in Sacramento, California between January and November 1999. Results: Of the mean total visit time of 15.9 min (S.D. = 434 s), a mean of 26 s (S.D. = 28 s) was allocated to guideline-recommended components and a mean of 23 s (S.D. = 25 s) was allocated to discussion of all other aspects of new prescription medications. The majority of time spent discussing individual new prescriptions was dedicated to: medication purpose or justification, directions and duration of use, and side effects. On average, more complete discussion of these components was associated with more time. More time was spent talking about guideline-recommended information if patients were in better health, if there was a third party in the room, and if the medication belonged to a psychiatric, compared to an ear, nose, throat medication class. Less time was spent discussing over-the-counter (OTC) medications and those prescribed to patients with a previous visit to the physician. Conclusion: Higher quality information transmission between physicians and patients about new medications requires more time, and may be difficult to achieve in short office visits. Practice implications: Time-compressed office visits may need to be redesigned to promote improved provider-patient communication about new medications.

Original languageEnglish (US)
Pages (from-to)311-319
Number of pages9
JournalPatient Education and Counseling
Volume72
Issue number2
DOIs
StatePublished - Aug 2008

Fingerprint

Prescriptions
Office Visits
Guidelines
Professional-to-Patient Infectious Disease Transmission
Tape Recording
Family Physicians
Pharynx
Nose
Ear
Psychiatry
Counseling
Communication
Delivery of Health Care
Physicians
Health

Keywords

  • Physician-patient relations
  • Prescription medication
  • Provider-patient communication
  • Time

ASJC Scopus subject areas

  • Medicine(all)

Cite this

How much time does it take to prescribe a new medication? / Tarn, Derjung M.; Paterniti, Debora A; Kravitz, Richard L; Heritage, John; Liu, Honghu; Kim, Sue; Wenger, Neil S.

In: Patient Education and Counseling, Vol. 72, No. 2, 08.2008, p. 311-319.

Research output: Contribution to journalArticle

Tarn, Derjung M. ; Paterniti, Debora A ; Kravitz, Richard L ; Heritage, John ; Liu, Honghu ; Kim, Sue ; Wenger, Neil S. / How much time does it take to prescribe a new medication?. In: Patient Education and Counseling. 2008 ; Vol. 72, No. 2. pp. 311-319.
@article{440e6158ebb742c2a0b1fad7c20a0f8e,
title = "How much time does it take to prescribe a new medication?",
abstract = "Objective: To measure the length of time spent discussing all aspects of new prescriptions and guideline-recommended aspects of counseling, and to evaluate factors associated with duration of discussion. Methods: We analyzed tape recordings in which 181 patients received 234 new medication prescriptions from 16 family physicians, 18 internists, and 11 cardiologists in 2 healthcare systems in Sacramento, California between January and November 1999. Results: Of the mean total visit time of 15.9 min (S.D. = 434 s), a mean of 26 s (S.D. = 28 s) was allocated to guideline-recommended components and a mean of 23 s (S.D. = 25 s) was allocated to discussion of all other aspects of new prescription medications. The majority of time spent discussing individual new prescriptions was dedicated to: medication purpose or justification, directions and duration of use, and side effects. On average, more complete discussion of these components was associated with more time. More time was spent talking about guideline-recommended information if patients were in better health, if there was a third party in the room, and if the medication belonged to a psychiatric, compared to an ear, nose, throat medication class. Less time was spent discussing over-the-counter (OTC) medications and those prescribed to patients with a previous visit to the physician. Conclusion: Higher quality information transmission between physicians and patients about new medications requires more time, and may be difficult to achieve in short office visits. Practice implications: Time-compressed office visits may need to be redesigned to promote improved provider-patient communication about new medications.",
keywords = "Physician-patient relations, Prescription medication, Provider-patient communication, Time",
author = "Tarn, {Derjung M.} and Paterniti, {Debora A} and Kravitz, {Richard L} and John Heritage and Honghu Liu and Sue Kim and Wenger, {Neil S.}",
year = "2008",
month = "8",
doi = "10.1016/j.pec.2008.02.019",
language = "English (US)",
volume = "72",
pages = "311--319",
journal = "Patient Education and Counseling",
issn = "0738-3991",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - How much time does it take to prescribe a new medication?

AU - Tarn, Derjung M.

AU - Paterniti, Debora A

AU - Kravitz, Richard L

AU - Heritage, John

AU - Liu, Honghu

AU - Kim, Sue

AU - Wenger, Neil S.

PY - 2008/8

Y1 - 2008/8

N2 - Objective: To measure the length of time spent discussing all aspects of new prescriptions and guideline-recommended aspects of counseling, and to evaluate factors associated with duration of discussion. Methods: We analyzed tape recordings in which 181 patients received 234 new medication prescriptions from 16 family physicians, 18 internists, and 11 cardiologists in 2 healthcare systems in Sacramento, California between January and November 1999. Results: Of the mean total visit time of 15.9 min (S.D. = 434 s), a mean of 26 s (S.D. = 28 s) was allocated to guideline-recommended components and a mean of 23 s (S.D. = 25 s) was allocated to discussion of all other aspects of new prescription medications. The majority of time spent discussing individual new prescriptions was dedicated to: medication purpose or justification, directions and duration of use, and side effects. On average, more complete discussion of these components was associated with more time. More time was spent talking about guideline-recommended information if patients were in better health, if there was a third party in the room, and if the medication belonged to a psychiatric, compared to an ear, nose, throat medication class. Less time was spent discussing over-the-counter (OTC) medications and those prescribed to patients with a previous visit to the physician. Conclusion: Higher quality information transmission between physicians and patients about new medications requires more time, and may be difficult to achieve in short office visits. Practice implications: Time-compressed office visits may need to be redesigned to promote improved provider-patient communication about new medications.

AB - Objective: To measure the length of time spent discussing all aspects of new prescriptions and guideline-recommended aspects of counseling, and to evaluate factors associated with duration of discussion. Methods: We analyzed tape recordings in which 181 patients received 234 new medication prescriptions from 16 family physicians, 18 internists, and 11 cardiologists in 2 healthcare systems in Sacramento, California between January and November 1999. Results: Of the mean total visit time of 15.9 min (S.D. = 434 s), a mean of 26 s (S.D. = 28 s) was allocated to guideline-recommended components and a mean of 23 s (S.D. = 25 s) was allocated to discussion of all other aspects of new prescription medications. The majority of time spent discussing individual new prescriptions was dedicated to: medication purpose or justification, directions and duration of use, and side effects. On average, more complete discussion of these components was associated with more time. More time was spent talking about guideline-recommended information if patients were in better health, if there was a third party in the room, and if the medication belonged to a psychiatric, compared to an ear, nose, throat medication class. Less time was spent discussing over-the-counter (OTC) medications and those prescribed to patients with a previous visit to the physician. Conclusion: Higher quality information transmission between physicians and patients about new medications requires more time, and may be difficult to achieve in short office visits. Practice implications: Time-compressed office visits may need to be redesigned to promote improved provider-patient communication about new medications.

KW - Physician-patient relations

KW - Prescription medication

KW - Provider-patient communication

KW - Time

UR - http://www.scopus.com/inward/record.url?scp=45649085310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45649085310&partnerID=8YFLogxK

U2 - 10.1016/j.pec.2008.02.019

DO - 10.1016/j.pec.2008.02.019

M3 - Article

VL - 72

SP - 311

EP - 319

JO - Patient Education and Counseling

JF - Patient Education and Counseling

SN - 0738-3991

IS - 2

ER -